Skip to main content
. 2013 Jul 24;4:467. doi: 10.3389/fpsyg.2013.00467

Table 1.

Description of demographic data and results of neuropsychological testing in amnestic mild cognitive impairment (aMCI) and healthy age-matched control groups.

Parameters Healthy elderly aMCI T (df = 40) p
DEMOGRAPHY
N 19 23
Age (years) 58.84 (7.41) 60.30 (9.31) 0.55 0.582
Gender (M/F) 8/11 5/18 2.02 0.192
Education (years) 14.74 (2.26) 13.09 (3.26) −1.87 0.069
Mini-mental state exam 29.32 (0.82) 28.91 (1.13) −1.30 0.201
CLINICAL CHARACTERISTICSa
Verbal fluency 29.53 (6.15) 22.61 (5.70) 3.78 0.001
Boston naming test 14.74 (0.45) 14.04 (1.11) 2.74 0.010
Word list learning 22.58 (2.78) 18.70 (2.99) 4.33 0.000
Word list recall 8.79 (1.08) 5.87 (1.71) 6.43 0.000
Word list: savings 0.97 (0.09) 0.78 (0.22) 3.75 0.001
Word list intrusions 0.16 (0.50) 0.65 (0.98) 2.10 0.043
Word list recognition 20.00 (0.00) 19.61 (0.66) 2.86 0.009
Phonematic fluency 18.68 (3.43) 13.65 (5.01) 3.72 0.001
TMT-A 30.67 (7.81) 45.39 (20.41) 2.89 0.006
TMT-B 69.33 (26.42) 84.83 (35.43) 1.55 0.130
Constructional praxis 10.95 (0.23) 10.74 (0.69) −1.36 0.184
Recall of constructional praxis 10.58 (0.84) 8.48 (1.93) 4.72 0.000
Constructional praxis: savings 0.96 (0.06) 0.79 (0.17) 4.50 0.000

Statistical tests of possible group differences (T-values and p-values) are presented.

aMCI, amnestic mild cognitive impairment; denoted are mean values, standard deviations (in brackets), T-, degrees of freedom (df) and p-values.

a

Clinical characteristics are mean raw-scores from subtests of the neuropsychological test battery contained in the Consortium to Establish a Registry for Alzheimer's Disease Plus (CERAD-Plus).

Significant values (p < 0.05) are marked in bold font.